Corrigendum to “Antihypertensive medication classes and risk of incident dementia in primary care patients: a longitudinal cohort study in the Netherlands” [The Lancet Regional Health—Europe, Volume 42, July 2024, 100927] (The Lancet Regional Health - Europe (2024) 42, (S2666776224000942), (10.1016/j.lanepe.2024.100927))

Publication date

2024-12

Authors

Schroevers, Jakob L.
Hoevenaar-Blom, Marieke P.
Busschers, Wim B.
Hollander, MonikaISNI 0000000392553595
Van Gool, Willem A.
Richard, Edo
Van Dalen, Jan Willem
Moll van Charante, Eric P.

Editors

Advisors

Supervisors

Document Type

Comment

Collections

Open Access logo

License

cc_by

Abstract

The authors have identified an error in the introduction of the main text. The correct statement should read: “Hypertension is an important risk factor for all-cause dementia, including Alzheimer's disease (AD). It affects over 70% of adults aged 60 and older,” rather than “Hypertension is an important risk factor for all-cause dementia, including Alzheimer's disease (AD), which is the cause of dementia in over 70% of adults aged 60 and older.” This correction pertains solely to the background information of this paper and does not impact the study's results or interpretations in any way. We apologize for any confusion this may have caused and are available to address any questions or comments.

Keywords

Internal Medicine, Oncology, Health Policy

Citation

Schroevers, J L, Hoevenaar-Blom, M P, Busschers, W B, Hollander, M, Van Gool, W A, Richard, E, Van Dalen, J W & Moll van Charante, E P 2024, 'Corrigendum to “Antihypertensive medication classes and risk of incident dementia in primary care patients : a longitudinal cohort study in the Netherlands” [The Lancet Regional Health—Europe, Volume 42, July 2024, 100927] (The Lancet Regional Health - Europe (2024) 42, (S2666776224000942), (10.1016/j.lanepe.2024.100927))', The Lancet Regional Health - Europe, vol. 47, 101132. https://doi.org/10.1016/j.lanepe.2024.101132